Ab Development Karolinska Net Worth & Insider Trades
Ab Development Karolinska Aprea Therapeutics, Inc
What is Ab Development Karolinska's Net Worth?
The current estimated net worth of Aprea Therapeutics, Inc's Ab Development Karolinska is estimated to be about $26.1M . Ab Development Karolinska owns about 1,992,586 units of Aprea Therapeutics, Inc common stock. In the last year at Aprea Therapeutics, Inc, Ab Development Karolinska has sold an estimated value of $14.93M worth.
What is Ab Development Karolinska's Past Insider Trading?
Ab Development Karolinska's largest sale order was 241,703 units , worth over $8.35M on July 7, 2020. In total, Ab Development Karolinska has made about 3 transactions over a year of their time at Aprea Therapeutics, Inc. Ab Development Karolinska usually trades in April, July and October, with the busiest year in 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AB Investments KDev, AB Development Karolinska, KB Fund CoInvestment KCIF
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Ab Development Karolinska's' Mailing Address?
- Mailing address is Tomtebodavagen 23a Solna V7 SE 171 65 Sweden
What are Aprea Therapeutics, Inc's Past Insider Trades?
Aprea Therapeutics, Inc's most recent insider trade came on June 8, 2023 by Bernd Seizinger who bought 10,097 units worth $36.96K . In the last 4 years, insiders at Aprea Therapeutics, Inc have sold an estimated value of $64.14M and bought an estimated value of $29.68M worth of shares. Insider trading is most common in March, with the busiest year in 2022 and 2020. The most active traders at the company are Alan Gregory Korbel, SVP, Christian Schade, Director, and Eyal Attar, SVP .
Aprea Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |